Literature DB >> 8126349

Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice.

K M Reiser1.   

Abstract

This study was designed to investigate the effects of lifetime diet restriction on collagen crosslinking in skin, tail tendon, aorta, and lung in mice. Difunctional enzymatic crosslinks decreased with age in all tissues except skin, while mature crosslinks showed almost no change with age. Collagen-associated fluorescence, assayed in skin and tail tendon, increased with age, as did pentosidine, a specific advanced glycation product, in aorta. There was no change in glucitolyllysine content with age. Difunctional crosslinks, glucitolyllysine, and collagen-associated fluorescence were decreased in diet-restricted animals relative to ad libitum fed animals in some tissues at some time points; however, correlations were not observed among these different effects, or between different tissues. Diet restriction did not affect nonreducible "mature" crosslinks. These studies suggest that: (1) lifetime diet restriction is associated with decreased collagen-associated fluorescence, suggestive of advanced glycation products, in older animals; (2) age-related increases in collagen stiffening and its decrease by dietary restriction cannot be explained solely by alterations in lysyl oxidase-mediated crosslinking, the levels of which are tissue dependent; (3) lysyl oxidase-mediated crosslinking and nonenzymatic glycation of collagen are independently influenced by dietary restriction and aging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126349     DOI: 10.1093/geronj/49.2.b71

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  9 in total

1.  An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

Authors:  M Asif; J Egan; S Vasan; G N Jyothirmayi; M R Masurekar; S Lopez; C Williams; R L Torres; D Wagle; P Ulrich; A Cerami; M Brines; T J Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Quantitative trait loci analysis of tail tendon break time in mice of C57BL/6J and DBA/2J lineage.

Authors:  Lauren B Sloane; Joseph T Stout; David J Vandenbergh; George P Vogler; Glenn S Gerhard; Gerald E McClearn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-11-03       Impact factor: 6.053

3.  Analyses of lysine aldehyde cross-linking in collagen reveal that the mature cross-link histidinohydroxylysinonorleucine is an artifact.

Authors:  David R Eyre; MaryAnn Weis; Jyoti Rai
Journal:  J Biol Chem       Date:  2019-02-07       Impact factor: 5.157

Review 4.  You Say You Want a Resolution (of Fibrosis).

Authors:  Kamran Atabai; Christopher D Yang; Michael J Podolsky
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

5.  Advanced glycation end-product accumulation reduces vitreous permeability.

Authors:  On-Tat Lee; Samuel D Good; Ricardo Lamy; Max Kudisch; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

6.  Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice.

Authors:  Kathryn Rutter; David R Sell; Nalani Fraser; Mark Obrenovich; Michael Zito; Pamela Starke-Reed; Vincent M Monnier
Journal:  Int J Vitam Nutr Res       Date:  2003-11       Impact factor: 1.784

7.  Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.

Authors:  Svenja Illien-Junger; Fabrizio Grosjean; Damien M Laudier; Helen Vlassara; Gary E Striker; James C Iatridis
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

8.  Advanced glycation end products: Key players in skin aging?

Authors:  Paraskevi Gkogkolou; Markus Böhm
Journal:  Dermatoendocrinol       Date:  2012-07-01

Review 9.  Collagen Biosynthesis, Processing, and Maturation in Lung Ageing.

Authors:  Ceylan Onursal; Elisabeth Dick; Ilias Angelidis; Herbert B Schiller; Claudia A Staab-Weijnitz
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.